The efficacy and safety of 2.5% testosterone gel for late-onset hypogonadsism patients evaluated by using salivary testosterone.
Not Applicable
- Conditions
- ate-onset hypogonadism
- Registration Number
- JPRN-UMIN000001011
- Lead Sponsor
- Teikyo University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Patients having serious heart, iver, and renal dysfunction. Pasients who have serious pshychiatric problems are also excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method